Position in DXCM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,224,785
+$919,774 QoQ
Shares Held
47,881
+30.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#326
of 973 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026TRILLIUM ASSET MANAGEMENT, LLC holds $49,909,351 across 7 Medical Devices names. DXCM ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
71,991 | $22,665,646 | |
| 2 | BSX |
Boston Scientific Corp
|
303,755 | $12,964,263 | |
| 3 | PEN |
Penumbra Inc
|
17,857 | $5,638,347 | |
| 4 | DXCM |
Dexcom Inc
This page
|
47,881 | $3,224,785 | |
| 5 | TMDX |
TransMedics Group, Inc.
|
41,577 | $2,761,544 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
|
18,437 | $2,193,081 | |
| 7 | ABT |
Abbott Laboratories
|
5,088 | $461,685 |
All Filings in DXCM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,224,785 | 47,881 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,305,011 | 36,704 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||